CLINICAL TRIALS PROFILE FOR ALOSETRON HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for ALOSETRON HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00067457 ↗ | Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy | Completed | GlaxoSmithKline | Phase 3 | 2003-06-01 | The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy. |
| NCT00067561 ↗ | Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy | Completed | GlaxoSmithKline | Phase 3 | 2003-06-01 | The purpose of this study is to compare the safety and effectiveness of different doses of an investigational medication in women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy. |
| NCT00130741 ↗ | Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) | Completed | Hadassah Medical Organization | Phase 1 | 2005-07-01 | This is an 8-week double-blind, placebo-controlled, randomized, parallel-group study with an additional two week baseline observation period to evaluate the safety of combination herbal therapy (CHT) versus placebo and short and long-term efficacy in terms of improved IBS, overall quality of life (QOL) and symptomatology. |
| NCT00370032 ↗ | Study to Assess the Effect Of Alosetron On Mucosal Blood Flow | Completed | GlaxoSmithKline | Phase 4 | 2006-12-01 | This study will look at colonic mucosal blood flow in subjects who have taken alosetron vs placebo and healthy volunteers vs diarrhea-predominant Irritable Bowel Syndrome (d-IBS) patients. |
| NCT01855711 ↗ | Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) | Completed | GlaxoSmithKline | Phase 2 | 2003-09-18 | This study is an exploratory study aiming (i) to obtain clinical experience of GR68755 in Japanese subjects with severe d-IBS to explore the feasibility of the next phase study and (ii) to obtain reference data for endpoints and dosage and administration of a next phase study. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ALOSETRON HYDROCHLORIDE
Condition Name
| Condition Name for ALOSETRON HYDROCHLORIDE | |
| Intervention | Trials |
| Irritable Colon | 4 |
| Irritable Bowel Syndrome (IBS) | 3 |
| Colonic Diseases, Functional | 1 |
| Irritable Bowel Syndrome of Diarrhea Type (IBS-D) | 1 |
| [disabled in preview] | 1 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for ALOSETRON HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for ALOSETRON HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for ALOSETRON HYDROCHLORIDE
Sponsor Name
